Inventor

KOSTLAN CATHERINE R

US37 patents

⚠️ This page may combine multiple inventors who share the name “KOSTLAN CATHERINE R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KOSTLAN CATHERINE R

WARNER LAMBERT CO

N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents

Analogues of pyrrolo[3,2d]pyrimidin-4-ones

3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents

Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines

5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents

3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents

3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents

2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents

N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents

Novel process for the preparation of pyrazoles from isoxazoles

Process of preparing pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxygenase inhibitors

2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents

2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents

2-substituted amino-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines as antiinflammatory agents

2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents

2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents

Biphenyl oxadiazoles and thiadiazoles as angiothesin II antagonists

2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents

2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents

N-hydroxyamide, N-hydroxythioamide, N-hydroxyurea, and N-hydroxythiourea derivatives of selected NSAIDS as antiinflammatory agents

Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents

5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents

2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents

2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents

Thiadiazole or oxadiazole analogs of fenamic acids containing substituted hydroxamate side chains as antiinflammatory agents

2-carbonyl substituted-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents

3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues

9-deazaguanines to treat psoriasis

Novel fenamic acid methyl hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition

Novel 9-deazaguanines

5-hydroxy-2-pyrimidinylmethylene oxaza heterocycles

Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxygenase inhibitors, pharmaceutical compositions and methods of use therefor

Biphenyl oxadiazoles and thiadiazoles as angiotensin II antagonists

Method of treating gout with novel 9-deazaguanines

9-deazaguanines

GRACEWAY PHARMACEUTICALS LLC

Method for decreasing sebum production

KOSTLAN CATHERINE R

Method for decreasing sebum production